NetWorth
LeaderPortfolio
Punia
Vikram Punia
Rank #2021
RUSSIA•Healthcare•Pharmaceuticals

Vikram Punia

Net Worth
$2.03B
0% (24h)
Vikram Punia is a Russian billionaire and the sole owner of Pharmasyntez, a leading pharmaceutical company in Russia. His source of wealth stems from the healthcare industry, specifically from the production of a wide range of medications, including those for tuberculosis, HIV, and cancer. Punia's career began in Russia in 1992, when he arrived in Irkutsk as a student. He founded Pharmasyntez in 1997, which has since become a major player in the Russian pharmaceutical market. As of March 2026, Punia's estimated net worth is $2.0 billion.

How to read Vikram Punia's profile

Public net-worth figures are estimates. They combine observable inputs—typically listed equity, disclosed transactions, and market prices—with editorial judgment where filings are incomplete (for example, private holdings, debt, or cross-holdings). For Vikram Punia, we anchor the narrative to Pharmaceuticals and Pharmaceuticals, then update the headline number as markets move. The chart on this page is meant to show trajectory, not a certified balance sheet.

When you see $2.03B alongside global rank #2021, interpret it as our best synthesis of widely cited ownership and price signals—not a claim about cash on hand. Estimates can diverge from other publishers because of different treatment of options, trusts, charitable vehicles, or illiquid assets. We document the general approach in methodology and welcome corrections via corrections.

Country (RUSSIA) and career milestones on this page are curated for reader context; they should be verified against primary sources when used for research. Editorial metadata for this profile is refreshed on a rolling basis, with deeper audits at least annually (last noted cycle: 2026).

Looking for depth? When available, the dossier and timeline sections below add long-form context beyond the headline number—prioritize those modules when evaluating claims about strategy, controversies, or philanthropic commitments.

The Full Dossier

Early Life

Vikram Singh Punia was born in Jaipur, India, in 1973. He came from a family with a wealthy background. In 1992, at the age of 19, he arrived in Irkutsk, Russia, through a student exchange program, to study medicine.

Rise to Success

Punia started his business journey by reselling goods like tea, leather jackets, and pantyhose. He later transitioned into the pharmaceutical industry, founding Pharmasyntez in 1997 in Irkutsk. The company initially repackaged generic antitubercular medicine imported from India. Over time, Pharmasyntez expanded, establishing multiple factories across Russia and producing a wide array of medicines. In 2008, Punia moved the company's headquarters to Moscow. In 2009, he became a Russian citizen and, in 2010, became the sole owner of Pharmasyntez.

Key Business Strategies

Pharmasyntez focused on producing high-quality, affordable medicines for critical diseases, including tuberculosis, HIV, and cancer. The company also played a role in producing the Sputnik Light coronavirus vaccines during the COVID-19 pandemic. Vikram Punia emphasized import substitution, replacing imported drugs with Russian-made alternatives, and pursued vertical integration, encompassing R&D, manufacturing, and distribution.

Philanthropy

While specific philanthropy amounts are unavailable, Pharmasyntez focuses on providing affordable medicines for critical diseases.

Career Timeline

2024

Order of Friendship

Awarded the Order of Friendship by the President of the Russian Federation

2010

Sole Ownership of Pharmasyntez

Became the sole owner of Pharmasyntez

2009

Became a Russian Citizen

Obtained Russian citizenship

2008

Moved Headquarters to Moscow

Relocated Pharmasyntez's headquarters to Moscow

1997

Founded Pharmasyntez

Established pharmaceutical company in Irkutsk, Russia

Philanthropic Impact

HealthcareN/A

Affordable Medicines

Providing affordable medications for the treatment of diseases like tuberculosis, HIV, and cancer.

Key Business Ventures & Holdings

CompanyStakeValue
Pharmasyntez100.00%$2M

Net Worth History

In-Depth Analysis

Early Life

Vikram Singh Punia was born in Jaipur, India, in 1973. He came from a family with a wealthy background. In 1992, at the age of 19, he arrived in Irkutsk, Russia, through a student exchange program, to study medicine.

Rise to Success

Punia started his business journey by reselling goods like tea, leather jackets, and pantyhose. He later transitioned into the pharmaceutical industry, founding Pharmasyntez in 1997 in Irkutsk. The company initially repackaged generic antitubercular medicine imported from India. Over time, Pharmasyntez expanded, establishing multiple factories across Russia and producing a wide array of medicines. In 2008, Punia moved the company's headquarters to Moscow. In 2009, he became a Russian citizen and, in 2010, became the sole owner of Pharmasyntez.

Key Business Strategies

Pharmasyntez focused on producing high-quality, affordable medicines for critical diseases, including tuberculosis, HIV, and cancer. The company also played a role in producing the Sputnik Light coronavirus vaccines during the COVID-19 pandemic. Vikram Punia emphasized import substitution, replacing imported drugs with Russian-made alternatives, and pursued vertical integration, encompassing R&D, manufacturing, and distribution.

Philanthropy

While specific philanthropy amounts are unavailable, Pharmasyntez focuses on providing affordable medicines for critical diseases.

Data Sources & Methodology

Figures for Vikram Punia are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.

You may also like

HubAll BillionairesHubGlobal RankingsHubNewsroom